Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
ROIC: Returns DecliningContracting
Percentile Rank62
Studio
Year-over-Year Change

Return on invested capital

Latest
-70.45%
↑ 40% vs avg
Percentile
P62
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-116.63%
Historical baseline
PeriodValueYoY Change
2025-70.45%-48.4%
2024-47.47%+70.7%
2023-161.73%+23.5%
2022-211.35%-56.8%
2021-134.75%-
20200.00%+100.0%
2019-66.95%+24.9%
2018-89.20%-337.4%
201737.57%+108.9%
2016-421.97%-